Proteomics International Laboratories Limited (PIQ.AX)

1.0500 -0.0400 (-3.67%) As of 02:31PM AEST. Market open.

Proteomics International Laboratories Limited

QEII Medical Centre
QQ Block 6 Verdun Street Nedlands
Perth, WA 6009
Australia
61 8 9389 1992
https://www.proteomics.com.au

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Richard John Lipscombe M.A., MA (Oxford), Ph.D., Ph.D., (London)	Co-Founder, MD & Director	442k	N/A	N/A
Ms. Jacqueline Gray	Chief Financial Officer	261.95k	N/A	N/A
Mr. John Chuck Morrison	Head of Business Development	N/A	N/A	N/A
Dr. Scott Bringans	Head of Research	N/A	N/A	N/A
Dr. Pearl Tan	Head of Product Development	N/A	N/A	N/A
Mr. Vikesh Malik	Chief Commercialisation Officer	240k	N/A	N/A
Dr. Kirsten Peters	Head of Clinical Studies	N/A	N/A	N/A
Ms. Karen Teresa Logan ACIS, B.Com., BCom, DipAppCorpGov, F Fin, FCIS, FC	Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. The company was founded in 2001 and is based in Perth, Australia.

Corporate governance

Proteomics International Laboratories Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.